Recent Updates
Recently added Catalysts
BBIO Neutral Sentiment

BridgeBio to Host Second Quarter 2025 Financial Results Conference Call on Tuesday, August 5, 2025 at 4:30 pm ET

Tuesday, July 22, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: BridgeBio Pharma, Inc. has announced that it will release its financial results for the second quarter of 2025 on August 5, 2025, after market close. A conference call to discuss these results and provide business updates is scheduled for the same day at 4:30 pm ET. Investors will be able to access the live webcast on the company's website, with a replay available for 30 days following the event.
Price reaction · baseline $45.9 (2025-07-21 close) · hit after-hours · clean, no other BBIO news in the window
day 0 close · peak
-0.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • BridgeBio is focused on addressing genetic diseases.
  • The upcoming financial results may indicate positive company performance.
  • Access to the presentation via webcast increases transparency with investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+41%
120-day peak, hindsight
Typical move
3.6%
average across 13 past catalysts
Cash runway
~30 mo
Minimal dilution risk
Lead asset
acoramidis
Phase 3 · Amyloidosis

Full Press Release Details

PALO ALTO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that it will release its second quarter financial results and business updates after the market closes on Tuesday, August 5, 2025. BridgeBio will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day.
To access the live webcast of BridgeBio’s presentation, please visit the “Events & Presentations” page within the Investors section of the BridgeBio website at investor.bridgebio.com/events-and-presentations/. A replay of the webcast will be available on the BridgeBio website for 30 days following the event.
Participants may access the webcast by registering online using the following link, https://events.q4inc.com/attendee/951604231.
About BridgeBio Pharma, Inc.
BridgeBio Media Contact:
Bubba Murarka, Executive Vice President, Corporate Development
contact@bridgebio.com
BridgeBio Investor Contact:
Chinmay Shukla, Senior Vice President, Strategic Finance

Frequently Asked Questions

When will BridgeBio release its Q2 financial results?

BridgeBio will release its second quarter financial results on August 5, 2025.

What time is the BridgeBio conference call scheduled?

The conference call is scheduled for 4:30 pm ET on August 5, 2025.

How can I access the BridgeBio webcast?

The webcast can be accessed via the 'Events & Presentations' page on their website.

Is the BridgeBio webcast replay available?

Yes, a replay of the webcast will be available for 30 days after the event.

Who is the media contact at BridgeBio?

Bubba Murarka is the media contact at BridgeBio Pharma.

ShareAdd on Google
Tags: BBIO Viatris Investor Conferences Healthcare BridgeBio financial results Q2 2025 conference call biotech
Last updated: Jul 22, 2025

Biotech snapshot

Cash runway
$720M liquidity · $24M/mo burn
~30 mo
Minimal dilution risk
Lead asset
acoramidisPhase 3
Amyloidosis →

Catalyst track record

+41%
best trade around BBIO's most recent catalyst

Peak hindsight return over a 120-day window, across 13 tracked FDA/PDUFA catalysts for BBIO.

See every catalyst's timing & PoA →